ZA811125B - Vaccinal complex containing a specific antigen and vaccine containing it - Google Patents
Vaccinal complex containing a specific antigen and vaccine containing itInfo
- Publication number
- ZA811125B ZA811125B ZA00811125A ZA811125A ZA811125B ZA 811125 B ZA811125 B ZA 811125B ZA 00811125 A ZA00811125 A ZA 00811125A ZA 811125 A ZA811125 A ZA 811125A ZA 811125 B ZA811125 B ZA 811125B
- Authority
- ZA
- South Africa
- Prior art keywords
- specific antigen
- vaccinal
- vaccine
- complex
- complex containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8003707A FR2475900A1 (fr) | 1980-02-20 | 1980-02-20 | Complexe vaccinal contenant un antigene specifique et vaccin le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA811125B true ZA811125B (en) | 1982-03-31 |
Family
ID=9238765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00811125A ZA811125B (en) | 1980-02-20 | 1981-02-20 | Vaccinal complex containing a specific antigen and vaccine containing it |
Country Status (10)
Country | Link |
---|---|
US (1) | US4460575A (xx) |
EP (1) | EP0035429B1 (xx) |
JP (1) | JPS56131523A (xx) |
AT (1) | ATE13741T1 (xx) |
AU (1) | AU543201B2 (xx) |
CA (1) | CA1181691A (xx) |
DE (1) | DE3170913D1 (xx) |
ES (1) | ES500567A0 (xx) |
FR (1) | FR2475900A1 (xx) |
ZA (1) | ZA811125B (xx) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870053A (en) * | 1980-09-19 | 1989-09-26 | Roussel Uclaf | Novel compositions and processes |
US5567587A (en) * | 1983-01-10 | 1996-10-22 | Gen-Probe Incorporated | Method for detecting, the presence and amount of prokaryotic organisms using specific rRNA subsequences as probes |
US4650675A (en) * | 1983-08-18 | 1987-03-17 | The Children's Medical Center Corporation | Oligonucleotide conjugates |
GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
US4689222A (en) * | 1985-01-18 | 1987-08-25 | Mcmichael John | Methods and materials for alleviation of pain symptoms of malignant neoplasia |
US4692332A (en) * | 1985-01-18 | 1987-09-08 | Mcmichael John | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
US5346999A (en) * | 1985-01-18 | 1994-09-13 | Applied Biosystems, Inc. | Method of nucleic acid extraction |
JPS62502262A (ja) * | 1985-03-27 | 1987-09-03 | ブロンコスタット・プロプライアタリー・リミテツド | アジユバントを含有しないワクチン |
EP0220308A1 (en) * | 1985-04-30 | 1987-05-06 | Scripps Clinic And Research Foundation | Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods |
US4701323A (en) * | 1985-10-23 | 1987-10-20 | Iowa State University Research Foundation, Inc. | Vaccines for counteracting inhibition of neutrophil degranulation |
US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
FR2619122B1 (fr) * | 1987-08-03 | 1990-03-09 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
DE69126183D1 (de) * | 1990-08-20 | 1997-06-26 | Den Ichi Mizuno | LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente |
US7279162B1 (en) * | 1990-10-22 | 2007-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection |
US5506129A (en) * | 1991-05-24 | 1996-04-09 | Evans Medical Limited | Virus production |
JPH09163896A (ja) * | 1995-12-13 | 1997-06-24 | Sumitomo Pharmaceut Co Ltd | 胸膜炎病態モデル動物 |
FR2745186B1 (fr) * | 1996-02-26 | 1998-12-31 | Torossian Fernand Narbey | Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter |
DE19703437A1 (de) * | 1997-01-30 | 1998-08-06 | Luitpold Pharma Gmbh | Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen |
GB2325233B (en) * | 1997-05-16 | 2001-07-18 | Norsk Hydro As | Substrates having bound polysaccharides and bacterial nucleic acids |
US6610293B1 (en) | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
EP2158923B1 (en) | 1998-08-06 | 2013-02-27 | Mountain View Pharmaceuticals, Inc. | Peg-urate oxidase conjugates and use thereof |
WO2002045742A2 (en) * | 2000-09-12 | 2002-06-13 | U.S. Army Medical Research And Materiel Command | Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
GB2370838A (en) * | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex |
GB2370839A (en) * | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex useful for disease control |
WO2003060143A2 (en) * | 2001-10-26 | 2003-07-24 | Id Biomedical Corporation Of Washington | Efficient protein expression system |
US20080159976A1 (en) * | 2005-04-11 | 2008-07-03 | Jacob Hartman | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
RU2435847C2 (ru) | 2005-04-11 | 2011-12-10 | Савиент Фармасьютикалз, Инк. | Вариантная форма урат-оксидазы и ее использование |
US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
PL3321359T3 (pl) | 2005-04-11 | 2021-06-28 | Horizon Pharma Rheumatology Llc | Wariantowe postacie oksydazy moczanowej i ich zastosowanie |
WO2006125452A1 (en) * | 2005-05-23 | 2006-11-30 | Universite De Geneve | Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
ES2532804T3 (es) | 2006-04-12 | 2015-03-31 | Crealta Pharmaceuticals Llc | Purificación de proteínas con tensioactivo catiónico |
KR101861547B1 (ko) | 2009-06-25 | 2018-07-02 | 크레알타 파마슈티칼스 엘엘씨 | 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체매개 상실을 예측하는 방법 및 키트 |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725545A (en) * | 1971-02-03 | 1973-04-03 | R Maes | Enhancement of antibody production by nucleic acid-polycation complexes |
FR2253499B1 (xx) * | 1973-12-10 | 1977-11-04 | Fabre Sa Pierre | |
US3952097A (en) * | 1974-09-27 | 1976-04-20 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
FR2305990A1 (fr) * | 1975-04-02 | 1976-10-29 | Fabre Sa Pierre | Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens |
FR2360314A2 (fr) * | 1976-08-06 | 1978-03-03 | Fabre Sa Pierre | Nouveaux vaccins perfectionnes a base de fractions ribosomales |
FR2374911A1 (fr) * | 1976-12-21 | 1978-07-21 | Fabre Sa Pierre | Adjuvants d'immunite non specifique |
FR2388563A1 (fr) * | 1977-04-29 | 1978-11-24 | Fabre Sa Pierre | Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires |
US4285930A (en) * | 1977-12-08 | 1981-08-25 | Likhite Vilas V | Antigens comprising immunostimulant adjuvants and their use in immunotherapy |
-
1980
- 1980-02-20 FR FR8003707A patent/FR2475900A1/fr active Granted
-
1981
- 1981-02-19 DE DE8181400258T patent/DE3170913D1/de not_active Expired
- 1981-02-19 CA CA000371264A patent/CA1181691A/en not_active Expired
- 1981-02-19 AT AT81400258T patent/ATE13741T1/de not_active IP Right Cessation
- 1981-02-19 EP EP81400258A patent/EP0035429B1/fr not_active Expired
- 1981-02-20 JP JP2418381A patent/JPS56131523A/ja active Pending
- 1981-02-20 US US06/236,534 patent/US4460575A/en not_active Expired - Lifetime
- 1981-02-20 ES ES500567A patent/ES500567A0/es active Granted
- 1981-02-20 AU AU67501/81A patent/AU543201B2/en not_active Expired
- 1981-02-20 ZA ZA00811125A patent/ZA811125B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US4460575A (en) | 1984-07-17 |
ES8203226A1 (es) | 1982-04-16 |
FR2475900B1 (xx) | 1983-06-10 |
ES500567A0 (es) | 1982-04-16 |
CA1181691A (en) | 1985-01-29 |
AU6750181A (en) | 1981-08-27 |
EP0035429B1 (fr) | 1985-06-12 |
AU543201B2 (en) | 1985-04-04 |
DE3170913D1 (en) | 1985-07-18 |
FR2475900A1 (fr) | 1981-08-21 |
JPS56131523A (en) | 1981-10-15 |
ATE13741T1 (de) | 1985-06-15 |
EP0035429A1 (fr) | 1981-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3170913D1 (en) | Vaccinal complex containing a specific antigen and vaccine containing it | |
PH20502A (en) | Quarternary 6,11-dihydro-dibenzo-(b,e)-thiepine-11-n-alkyl-norscopine ethers | |
ES8801319A1 (es) | Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico. | |
EP0121249A3 (en) | Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine | |
NL300404I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
IL65835A0 (en) | Protozoal antigen,its preparation and vaccine containing it | |
ZA817896B (en) | Novel d-homosteroids | |
FR2471785B1 (xx) | ||
EP0018579A3 (en) | Babesiosis antigen, vaccine and diagnostic reagent comprising it | |
IL65496A0 (en) | Protozoal antigen,its preparation and vaccine containing it | |
IL59663A0 (en) | Vaccines obtained from bacterial mutant strains | |
ZA905927B (en) | Biological preparation and its use | |
DE3068224D1 (en) | Vaccines from taxonomically similar organisms | |
GR73033B (xx) | ||
IL58677A0 (en) | Process for the preparation of 1 ,3 -dihydroxy- -steroids and intermediates useful in the process | |
DE2960853D1 (en) | Intra-respiratory vaccine, modified bacteria strain used in it, vaccine dose form and process for preparing it | |
GB2024223B (en) | Process for the preparation of n,n'-disubstituted 2 - naphta - leneethan - imidamides and intermediates used therein | |
DE69130953D1 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
AU6361680A (en) | Babesiosis vaccine | |
IL63957A0 (en) | Bis-silylated 1-hydroxycycolopropanecarboxylic acids,their preparation and their use as intermediate products | |
JPS54140715A (en) | Vaccine stabilizer | |
IT7830203A0 (it) | Procedimento per rinforzare prodotti di carbone dolce. | |
DE2965852D1 (en) | Device for driving or extracting intramedullary nails | |
ZA806606B (en) | Specific antigen vaccine for tge in swine | |
CS194094B1 (en) | Vaccine against the aujeszki disease inactivated lyophilizised |